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Motor neurons are thought to critically regulate the survival of a subset of developing muscle ®bers. In muscles that
develop in the absence of innervation, primary muscle ®bers appear to form in normal numbers, but their long-term survival
is thought to require innervation-induced suprathreshold activity. Here I examine interactions between motor neurons
and muscle ®bers in newborn rats. I report that a small fraction of muscle ®bers in developing muscles undergo apoptosis.
Many, if not all, of these ®bers appear to have lost innervation owing to the retraction of nerve terminals. That the apoptosis
is initiated by the loss of functional innervation is suggested by a severalfold increase in the magnitude of ®ber apoptosis
following denervation and muscle paralysis. Finally, both naturally occurring and denervation-induced muscle ®ber
apoptosis can be prevented by exogenous administration of neuregulin. These results argue that the survival of all or a
subset of developing muscle ®bers is ultimately regulated by neuregulin. Furthermore, these results suggest a model in
which innervation-induced suprathreshold activity indirectly regulates muscle ®ber survival by modulating the levels of
neuregulin at developing neuromuscular junctions. q 1998 Academic Press
INTRODUCTION these ®bers are not maintained, and eventually atrophy and
degenerate, possibly as a result of their apoptotic death
(McClearn et al., 1995). In contrast, fewer later generationThe regulation of the numbers of muscle ®bers and of the
number of motor neurons that innervate them is thought or secondary ®bers form in the absence of innervation or in
paralyzed muscles (Fredette and Landmesser, 1991; Condonto depend on signaling interactions during development.
The adult size of the motor pool innervating a muscle is et al., 1990; Hughes and Ontell, 1992; Ashby et al., 1993a,b).
Ashby et al. (1993b) have proposed that the generation ofdetermined by the death of a large portion of the motor
neurons that initially reach the target muscle. The survival/ secondary muscle ®bers is regulated by the amount of activ-
ity experienced by the primary muscle ®bers.death of motor neurons appears to be determined by compe-
tition among the motor neurons for a limited supply of Here I show that muscle ®bers undergo apoptosis in new-
born rats, and that ®ber apoptosis is correlated with the lossmuscle-derived factors, since the number of surviving mo-
tor neurons is augmented by an increase in the size of target of all innervation. The magnitude of muscle ®ber apoptosis
is increased both by denervation and muscle paralysis, andmuscles achieved by transplantation but is attenuated by
removal of target muscle (Hollyday and Hamburger, 1976; both naturally occurring and denervation-induced apoptosis
can be prevented by exogenous administration of glialOppenheim, 1991). Furthermore, motor neuron survival can
be promoted in vitro as well as in vivo by muscle extracts growth factor II (GGF2), a member of the neuregulin family
of trophic factors (Marchionni et al., 1993). These resultsand by muscle-derived growth factors (Grinnell, 1995).
Motor neurons, in turn, appear to regulate the numbers argue that muscle cell survival is regulated indirectly by
innervation-induced suprathreshold activity and directly byof their targets by in¯uencing the generation and survival
of ®bers in developing muscles. In muscles that develop in neuregulin. A model is proposed in which motor neurons
promote the survival of primary muscle ®bers indirectly,the absence of innervation (Ross et al., 1987; Hughes and
Ontell, 1992; Ashby et al., 1993a) or excitation±contraction by modulating the synaptic levels of neuregulin through
the activity they induce in target muscle ®bers.coupling (Ashby et al., 1993b), the earliest forming or pri-
mary muscle ®bers are generated in normal numbers, but
METHODS
1 Current address: Department of Physiology, University of Califor-
nia, San Francisco, 515 Parnassus Avenue, San Francisco, California Surgery. Soleus muscles were denervated by resection of the
sciatic nerve as it exits the sciatic notch. Levator auris longus mus-94143-0444. Fax: (415) 476-4929. E-mail: joshua@phy.ucsf.edu.
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cles were denervated by resection of the posterior auricular nerve
as it exits the stylomastoid foramen. Wounds were closed with 8-
O suture and pups were then returned to their mothers.
Immunohistochemistry. At the time of the acute experiment,
muscles were dissected free in oxygenated Ringers (Liley, 1956),
®xed in 4% phosphate-buffered paraformaldehyde for 10 min at
room temperature and then rinsed in phosphate-buffered saline
(PBS) for 30 min. Fixed muscles were permeabilized in absolute
methanol for 6 min at 0207C and again washed in PBS for 30 min.
Apoptotic nuclei were labeled using a commercial kit (Oncor,
Apoptag, Gaithersburg, MD). Brie¯y, terminal deoxynucleotidyl-
transferase (TdT) was used to catalyze the template-independent
addition of digoxigenin-conjugated deoxyribonucleotide triphos-
phate (dUTP) to the 3*-OH ends of fragmenting DNA. FITC-conju-
gated anti-digoxigenin antibodies were then used to visualize the
tagged DNA. This technique is referred to as the TUNEL technique,
which is terminal dUTP nick end labeling (Gavrieli et al., 1992).
In some preparations, nuclei were labeled with propidium iodide
(Sigma, St. Louis, MO, P-4170, used at 50 mg/10 ml PBS). Axons
and their terminals were jointly labeled with primary antibodies
to the 200-kDa neuro®lament protein (Developmental Studies Hy-
bridoma Bank, Baltimore, MD, 2H3, used at 1:200), and to synapto-
physin (Sigma, S-5768, used at 1:400). An FITC-conjugated anti-
mouse secondary antibody (Sigma, F-2266, used at 1:100) was used
to visualize binding of these primary antibodies. Despite their label-
ing with the same ¯uorochrome (FITC) nerve terminals were easily
distinguished from apoptotic nuclei. Acetylcholine receptors were
labeled with TRITC-conjugated a-bungarotoxin. Images were ac-
quired using either a Leica DMRX epi¯uorescent microscope and
an integrating CCD camera, or a Leica TCS 4D laser scanning
confocal microscope. Confocal images were analyzed as maximal
projections of the optical sections. Both microscopes were equipped
for differential interference contrast.
Botulinum toxin paralysis. Two nanograms of botulinum
toxin dissolved in a vehicle comprising 0.2% gelatin, 0.9% NaCl
in distilled water was administered directly over levator auris mus-
cles by subcutaneous injection. To assess the level of paralysis the
muscle nerve was drawn into a suction electrode and stimulated
at 1 and 20 Hz. Muscles were considered paralyzed if they failed
to contract following nerve stimulation.
Neuregulin administration. Recombinant human glial growth
factor II (1.26 mg, GGF2; Cambridge NeuroScience Inc., Cambridge,
MA) dissolved in 10 ml of vehicle (1% bovine serum albumin, 20
mM sodium acetate, 100 mM arginine, 1% mannitol, 100 mM
Na2SO4, pH 6.5) was applied directly over the levator auris longus
via subcutaneous injection. The concentration of GGF2 needed to
obtain half-maximal proliferation of cultures of Schwann cells is
6.78 ng ml01.
RESULTS FIG. 1. Characterization of muscle ®ber apoptosis in neonatal
muscles. (A) Low-power view of strings of TUNEL-labeled nuclei
in a P3 levator auris longus muscle denervated on P2. Muscle ®bersPreviously, it was reported that terminal Schwann cells,
run at an approximately 157 angle from horizontal. (B) Nomarskithe glial cells that cap motor nerve terminals at neuromus-
image of an apoptotic muscle. Note that the ®ber is fragmented,cular junctions, undergo apoptosis in response to denerva-
though it retains its striations. The arrow points to the pieces of ation of neonatal muscles (Trachtenberg and Thompson,
fragmented nucleus. This is the same nucleus that is also labeled1996). I report here that TUNEL-labeled nuclei in dener-
with the TUNEL technique in C. (C) TUNEL-labeled myonucleus.
vated, neonatal muscles are not exclusively associated with This nucleus is contained within the dying ®ber shown in B. (D)
dying Schwann cells. Long strings of TUNEL-labeled nuclei Propidium iodide-labeled myonucleus in a healthy muscle ®ber
running parallel to the long axis of the muscle ®bers are from a permeabilized P4 muscle. (E) TUNEL-labeled myonucleus
present as well (cf. Fig. 1A). In each of 6 soleus muscles an apoptotic muscle ®ber. Scale bar in A, 50 mm; B and C, 20 mm;
denervated between P0 and P2 and examined 1 and 2 days D and E, 30 mm.
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TABLE 1
Denervation and Botulinum Toxin-Induced Paralysis Increase Muscle Fiber Apoptosis
Denervation Muscle 1 Muscle 2 Muscle 3 Muscle 4 Muscle 5 Muscle 6 Mean (SEM)
Control P4 20 12 6 17 5 na 12 (3)
Den P3-4 55 63 38 52 25 na 46.6 (6.7)
Paralysis Muscle 1 Muscle 2 Muscle 3 Muscle 4 Muscle 5 Muscle 6 Mean (SEM)
Control P5 8 9 10 15 6 4 8.7 (1.5)
Veh P4-5 4 0 1 2 na na 1.7 (0.8)
BoTX P4-5 22 14 18 52 na na 26.5 (8.6)
Den P4-5 / veh 24 29 21 24 na na 24.5 (1.7)
Note. Total number of apoptotic muscle ®bers observed in each muscle from each group. Student's t test (unpaired) was used to evaluate
the signi®cance of the differences in the means between the groups. Denervation: P4 vs Den P3-4, P  0.005. Paralysis: P5 vs BoTX P4-
5, P  0.05; BoTX P4-5 vs Den P4-5 / veh, P  0.83; BoTX P4-5 vs veh P4-5, P  0.05. Abbreviations: P, postnatal day; Den, denervation;
veh, vehicle; BoTX, botulinum toxin.
later, between 11 and 33 strings of TUNEL-labeled nuclei revealed that these TUNEL-labeled nuclei were contained
within muscle ®bers (Figs. 1B and 1C). Muscle ®bers (580were observed. Because myo®bers are multinucleated cells,
and 610) were counted in whole-mount preparations of twothe alignment of these TUNEL-labeled nuclei into long
muscles viewed using Nomarski optics. Thus, approximatelystrings suggested that muscle ®bers, as well as Schwann
1 of every 50 ®bers is apoptotic in these young muscles.cells, in neonatal muscles are susceptible to denervation-
In contrast to myonuclei in healthy muscle ®bers, whichinduced apoptosis. Consistent with this ®nding, Soileau et
appear oblong when stained with either DAPI or propidiumal. (1987) reported that a signi®cant fraction of slow muscle
iodide (Fig. 1D), apoptotic myonuclei were often fragmented®bers (®bers derived from primary muscle ®bers) are lost
into small, round, TUNEL-labeled pieces (Fig. 1E). The mor-from soleus muscles permanently denervated on postnatal
phology of the muscle ®bers containing these TUNEL-la-day 2 and examined 5 to 10 days later.
beled nuclei was altered as well. Though retaining theirSimilar strings of TUNEL-labeled nuclei were seen in the
striations, dying muscle ®bers were fragmented into smallnormally innervated, contralateral soleus muscles as well
pieces ranging from 15 to 50 mm in length (Fig. 2, see also(n  5), though they were signi®cantly less frequent than
Figs. 1B and 3). Presumably these are apoptotic bodiesin denervated muscles (4.4 { 1.0 SEM per whole-mount
(Steller, 1995; Thompson, 1995). Interestingly, the smallerpreparation in normally innervated muscles versus 18.8 {
fragments had a decreased periodicity in their striations rel-3.2 SEM in denervated muscles; P 0.005, Student's t test).
ative to the longer fragments and to healthy ®bers (compareVerifying that these strings of TUNEL-labeled nuclei were,
the periodicity of the striations in the fragments in the up-in fact, myonuclei proved dif®cult in whole-mount prepara-
per panel of Fig. 2 to those of the fragment shown in thetions of soleus because these preparations are somewhat
lower panel of Fig. 2). One explanation of this is that oncethick and thus not readily imaged using differential interfer-
the longer fragments lose all continuity with the rest ofence contrast (Nomarski) microscopy, necessary for the ex-
the myo®ber, they contract, forming shorter and somewhatamination of muscle ®ber morphology. Additionally, the
wider fragments. Strings of apoptotic myonuclei were rarelythickness of soleus and the penetration of the reagents com-
seen to extend the entire length of the muscles. In some
plicates estimates of the numbers of dying cells. Because of cases, when individual apoptotic ®bers were followed for
these dif®culties in use of soleus, further examinations of some distance, there was an apparent progression of muscle
®ber apoptosis in normally innervated and denervated neo- ®ber apoptosis from the middle of the ®ber toward the myo-
natal muscles were made in the levator auris longus, a ¯at tendonous junction with more pronounced evidence of
sheet of muscle ®bers comprising only three muscle ®ber apoptosis (assayed on the basis of both TUNEL-labeled or
layers (Angaut-Petit et al., 1987). propidium iodide-labeled myonuclei and muscle ®ber frag-
mentation) seen near the middle of the ®ber (Fig. 3). When
the fragments of an individual muscle could be followedCharacterization of Naturally Occurring Muscle
from one tendon to the other, the fragments were alwaysFiber Apoptosis in the Levator Auris
of the short and wide variety shown in the upper panel
As in neonatal soleus muscles, long strings of TUNEL- of Fig. 2; and though not all of these fragments contained
labeled nuclei running parallel to the long axis of the muscle TUNEL-labeled myonuclei, the myonuclei observed were
®bers were present in whole-mount preparations of levator very pyknotic. These data suggest that as apoptosis proceeds
auris longus muscles removed from P3-P4 rat pups (Fig. 1A, the fragmentation of the ®bers and myonuclei becomes
more pronounced.Table 1). Combined epi¯uorescence and Nomarski imaging
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FIG. 2. Apoptotic ®bers fragment into small pieces that retain their striations. In both the upper and lower panels in this ®gure white
arrows point to the ®ber fragments. The upper panel shows two fragments of the same ®ber. These fragments are between 15 and 20 mm
in length. The lower panel shows one long fragment that is approximately 50 mm in length. Note that the periodicity in the striations is
shorter in the fragments in upper panel than in the lower panel. Scale bar, 20 mm.
TUNEL-labeled myonuclei were spaced 68 { 3 mm apart. would support a model in which muscle ®ber apoptosis
results from the failure of a recently formed ®ber to gainThis was on average greater than the spacing of myonuclei
in healthy, permeabilized ®bers stained with propidium io- innervation. An alternative explanation of muscle ®ber
maintenance has been put forth by investigators examiningdide (55 { 3 mm). However, all myonuclei in the few dying
®bers that were labeled with propidium iodide were seen the sexually dimorphic bulbocavernosus muscle. In female
rats, the bulbocavernosus muscle is present and function-to be pyknotic (cf. Fig. 3). These data suggest that nuclear
fragmentation is not restricted to a subset of myonuclei ally innervated at birth. However, this muscle degenerates
in females shortly thereafter, possibly as a result of thewithin the portion of the ®ber that is apoptotic.
No ®ber apoptosis was observed in levator auris muscles death of its motor pool. These data suggest that muscle
removed from P10 rat pups (n  3), suggesting that the ®ber degeneration results from the loss of previous motor
period of naturally occurring ®ber loss wanes during the innervation (Rand and Breedlove, 1987). Given these two
®rst week of early postnatal development. alternatives, an examination was made of the innervation
status of dying muscle ®bers in normally developing mus-
cles. The presence of an acetylcholine receptor (AChR) clus-
Dying Fibers in Normally Developing Muscles ter on an apoptotic muscle ®ber was taken as evidence of
Have Clustered Acetylcholine Receptors but former innervation.
Lack Overlying Nerve Terminal Branches In two muscles that were labeled with the TUNEL tech-
and Terminal Schwann Cells nique, with antibodies to synaptophysin and neuro®lament
(to label axons and their terminals), and with BTx to labelPrevious investigators examining muscle ®ber develop-
AChRs, 18 trains of TUNEL-labeled myonuclei were seenment in muscles rendered aneural either by a genetic muta-
that ran through the endplate region. No information on thetion that results in the failure of the common peroneal nerve
status of innervation of 11 of the ®bers containing these apop-to form (Ashby et al., 1993a) or by laser ablation of the
totic myonuclei could be obtained because a clearly resolvedlumbosacral spinal cord (Hughes and Ontell, 1992) have
Nomarski image of the muscle ®ber could not be obtainedreported that the number of primary muscle ®bers, though
or the ®ber was so atrophic in the region of the endplate bandinitially normal, decreases throughout development as an-
eural muscle ®bers atrophy and degenerate. These results that it could not be followed con®dently. Of the remaining 7
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FIG. 3. The onset of ®ber apoptosis is not uniform throughout a ®ber. A ®ber in the early stages of apoptosis imaged with Nomarski
optics and stained with the nuclear marker propidium iodide. The ®ber appears normal at one end: there are no signs of ®ber fragmentation
and no signs of nuclear pyknosis (left half of upper panel in the direction of the myotendonous junction). As the ®ber is followed toward
the endplate it becomes progressively more fragmented (middle panel, left side) and pyknotic myonuclei are clearly visible (black arrows
in all panels). Eventually (right half of lower panel), this ®ber cannot be followed further. Instead, a trail of debris is present as are large
numbers of nuclei. The origin of these nuclei is unclear, though they may be nuclei of macrophages. Scale bar, 20 mm.
apoptotic ®bers, 4 displayed no signs of previous innervation, ®ber innervated by a single motor neuron. However, loss of
all innervating axons may occur in an activity-independentsince no AChR cluster or nerve terminal could be identi®ed.
It should be noted, however, that the innervation of the leva- manner as proposed by Thompson and Jansen (1977) and by
Fladby and Jansen (1987). How such intrinsic withdrawaltor auris longus is complex: two endplate bands separated by
a few hundred micrometers are present in this muscle. Thus, occurs is poorly understood. One model put forth by Trach-
tenberg and Thompson (1997) suggests that terminalwhile an apoptotic ®ber may not have appeared to be inner-
vated at one endplate band, it may have been innervated at Schwann cells play important roles in stabilizing motor
nerve terminals: alterations in the position and morphologythe second. Given that a single muscle ®ber is dif®cult to
follow through both endplate bands, I cannot state with con- of terminal Schwann cells in developing muscles preceded
and were correlated with the withdrawal of all inputs to a®dence that these 4 apoptotic ®bers had never been inner-
vated. The remaining 3 of these 7 apoptotic muscle ®bers, developing ®ber. Given these results, an examination of the
terminal Schwann cells associated with dying ®bers washowever, had clearly been innervated (Fig. 4). In each case,
a large, well-clustered AChR plaque was present (Fig. 4B). made in two muscles jointly labeled with the TUNEL tech-
nique, antibodies to neuro®lament and synaptophysin, anti-Interestingly, although motor axons were seen to extend to
these dying ®bers, these motor axons lacked terminal arbori- bodies to the glial marker S100, and with bungarotoxin. In
these two muscles two apoptotic muscle ®bers with unam-zations (Fig. 4C), leaving all or a part of the underlying AChR
plaque devoid of innervation (Fig. 4D). biguous AChR plaques were found (one is shown in Fig. 5).
As with the muscles described above, axons projected toThe retraction of all inputs to a muscle ®ber is unlikely
to result from the activity-dependent competition between these ®bers, but the AChR plaques lacked overlying nerve
terminal branches. Terminal Schwann cells were absentmotor nerve terminals that ultimately leaves each muscle
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FIG. 4. Apoptotic muscle ®bers found in normal neonatal muscles were once innervated. (A) Nomarski image of an apoptotic muscle
®ber in a normally innervated, P3 muscle. The ®ber is fragmented and discontinuous. The central arrow in this panel points to the region
of the dying ®ber containing endplate 2 shown in B±D. The short, thick arrows in this panel point to adjacent fragments of the same
®ber. (B) Three endplates are shown. AChRs, labeled with BTx, remain clustered on the dying muscle ®ber, marking the former synaptic
site (thick arrow labeled ``2''). The two thin arrows in this panel (labeled ``1'' and ``3'') point to two AChR clusters on healthy, normally
innervated ®bers. (C) Axons labeled with antibodies to neuro®lament and synaptophysin. The arrows labeled ``1,'' ``2,'' and ``3'' point to
the positions of the AChR clusters shown in B with the same numeric label. The arrow labeled ``axon termination'' points to the end of
the motor axon that projects to endplate 2 on the dying ®ber. This axon does not ramify to cover the underlying AChR plaque, suggesting
that the terminal arborization has been retracted. The arrows labeled ``1'' and ``3'' in this panel point to the nerve terminal arbors that
cover the corresponding AChR plaques identi®ed by similar arrows in B. The axons that pass over endplate ``2'' are labeled ``passing
axons.'' (D) A color schematic of the synaptic sites shown in B and C displaying the precise overlay of axons and AChRs. The AChRs are
labeled in red, the innervating axon to endplate 2 is labeled in green, and the remaining axons that project to endplates 1 and 3 are labeled
in yellow. Endplates 1 and 3 are well covered by motor nerve terminals, whereas there are clearly large areas of endplate 2 that lack such
coverage. Scale bar, 20 mm.
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from the AChR rich regions as well, but were coextensive P10 rat pups (see above). To examine whether muscles are
susceptible to denervation-induced apoptosis at this age,with the motor axons (Fig. 5). However, while terminal
Schwann cells were absent, there were no signs of terminal 4 levator auris longus muscles were denervated on P10
and then removed and examined on P11. In these musclesSchwann cell apoptosis.
These data demonstrate that muscle ®ber apoptosis, at between 0 and 3 apoptotic ®bers were seen in each prepara-
tion. Terminal Schwann cells in these denervated muscles,least in some cases, is correlated with the retraction of all
previously innervating motor neurons and with the loss of, however, retained their susceptibility to denervation: ter-
minal Schwann cell nuclei were TUNEL-labeled, and theor failure to acquire, terminal Schwann cell coverage.
Schwann cells themselves were seen to have fragmented
into apoptotic bodies.Muscle Fiber Apoptosis Is Increased Following
These data suggest that muscle ®bers either lose theirDenervation and Muscle Paralysis
susceptibility to denervation-induced apoptosis, or that the
The results presented above argue that muscle ®ber
onset of apoptosis following denervation is delayed at this
apoptosis follows the loss of innervation. To examine this
age. Additionally, along with the data from the BoTX-para-
directly, levator auris muscles were denervated on postnatal
lyzed muscles (see above), these data further demonstrate
day 3 and examined one day later (n  5). In these muscles
that terminal Schwann cell apoptosis and muscle ®ber
there was a statistically signi®cant increase in the number
apoptosis are independently regulated.
of apoptotic muscle ®bers relative to normally innervated
muscles (Table 1). The morphological characteristics of ®-
ber apoptosis in denervated muscles were indistinguishable Muscle Fiber Apoptosis Can Be Prevented
from those in normally innervated muscles. by Application of Exogenous Neuregulin
These results demonstrate that innervation is critical for
The results presented in the preceding sections argue that
the survival of some developing muscle ®bers. Motor neu-
motor neurons regulate the survival of some muscle ®bers.
rons may regulate the survival of developing muscle ®bers
Previous studies have reached similar conclusions, though
by releasing some trophic factor, by inducing action poten-
they argue that muscle ®ber survival is ultimately regulated
tials in the muscle ®bers following release of acetylcholine,
by motor neuron-induced excitation contraction coupling
or both. Consistent with a role for nerve-induced electrical
(Ashby et al., 1993b). While the data reported here support
activity in regulating muscle ®ber apoptosis, Ashby et al.
this view, another possibility is that activity is required
(1993b) proposed that excitation contraction coupling was
for ®bers to produce and/or respond to trophic factors. The
required for the survival of primary muscle ®bers. To exam-
neuregulins, a family of alternatively spliced ligands for
ine whether suprathreshold activity is required for muscle
erbB receptor tyrosine kinases (Carraway and Burden, 1995;
®ber survival, levator auris muscles in P4 rat pups were
Lemke, 1996), have been demonstrated to in¯uence gene
paralyzed for 1 day with botulinum toxin (BoTX), an agent
expression in cultured muscle ®bers, and to stimulate myo-
that prevents the fusion of synaptic vesicles and thus halts
genesis in cultured myoblasts (Carraway and Burden, 1995;
synaptic transmission (n  4). The magnitude of muscle
Lemke, 1996; Florini et al., 1996) and are thus attractive
®ber apoptosis in these muscles was compared with that in
candidates for regulators of muscle ®ber apoptosis. Consis-
muscles from littermates that had been denervated on the
tent with such a role, motor neurons and muscle ®bers
day of the BoTX administration (e.g., P4), with muscles ex-
express neuregulin mRNA (Marchionni et al., 1993; Mos-
posed to vehicle alone, and with muscles left untreated (Ta-
coso et al., 1995), and neuregulin and its receptors erbB2,
ble 1). The magnitude of ®ber apoptosis in muscles para-
erbB3, and erbB4 are concentrated at neuromuscular junc-
lyzed with BoTX was signi®cantly greater than in both vehi-
tions by the early postnatal period, and possibly earlier
cle-exposed controls and untreated controls (Table 1).
(Goodearl et al., 1995; Moscoso et al., 1995; Sandrock et
However, there was no statistically signi®cant difference in
al., 1995; Zhu et al., 1995).
the magnitude of ®ber apoptosis between BoTX paralyzed
To examine whether neuregulin could prevent denerva-
and denervated muscles (Table 1). As previously reported
tion-induced apoptosis of muscle ®bers in vivo, GGF2, a solu-
(Trachtenberg and Thompson, 1996), there were no signs of
ble isoform of neuregulin, was applied via subcutaneous in-
terminal Schwann cell apoptosis in any of the BoTX para-
jection directly over levator auris longus muscles denervated
lyzed muscles. The signi®cance of this will be examined
on either P2 or P3. A single injection of 1.26 mg of GGF2 in
under Discussion.
10 ml of vehicle was administered following resection of the
These data demonstrate that suprathreshold activity is
muscle innervation, and muscles were examined 1 day later.
required for the survival of muscle ®bers. Furthermore,
Muscle ®ber apoptosis, assayed on the basis of both TUNEL-
these data demonstrate that terminal Schwann cell survival
labeled myonuclei and muscle ®ber fragmentation, was sig-
and muscle ®ber survival are independently regulated.
ni®cantly less in denervated, GGF2-exposed muscles than in
denervated muscles exposed to vehicle (Table 2). Given this
Muscle Fiber Susceptibility to Denervation Wanes result, an examination was made into whether exogenous
during the Second Postnatal Week neuregulin could also prevent the naturally occurring muscle
®ber apoptosis seen in normally innervated, neonatal mus-In normally developing muscles, no apoptotic muscle
®bers were seen in levator auris muscles removed from cles. Levator auris longus muscles exposed to a single appli-
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TABLE 2
Neuregulin Prevents Naturally Occurring and Denervation-Induced Paralysis
Treatment/age Muscle 1 Muscle 2 Muscle 3 Muscle 4 Muscle 5 Mean (SEM)
Control P4 20 12 6 17 5 12 (3)
GGF P3-4 0 0 1 na na 0.3 (0.3)
Den P3-4 55 63 38 52 25 46.6 (6.7)
Den P3-4 / GGF 13 14 1 2 3 6.6 (2.8)
Note. Total number of apoptotic muscle ®bers observed in each muscle from each group. Student's t test (unpaired) was used to evaluate
the signi®cance of the differences in the means between the groups: P4 vs NRG P3-4, P  0.05; denervation P3-4 vs denervation P3-4
/ NRG, P  0.001. Abbreviation: GGF, glial growth factor II.
cation of exogenous GGF2 on P2 or P3 and examined 1 day plaques. These data support hypotheses put forth by
Thompson and Jansen (1977) and by Fladby and Jansenlater (n  3) displayed from 0 to 1 apoptotic muscle ®bers
per muscle (Table 2). This was signi®cantly less than that (1987) that in addition to activity-dependent mechanisms,
there are also activity-independent mechanisms that resultseen in normally innervated P4 muscles exposed to vehicle
(Table 2). These data demonstrate that exogenous neuregulin in the retraction of nerve terminals from synaptic sites.
A number of possible explanations for the induction ofcan prevent both denervation-induced and naturally oc-
curring muscle ®ber apoptosis in vivo. naturally occurring muscle ®ber apoptosis present them-
selves. Given that Rich and Lichtman (1989) and Van Mier
and Lichtman (1994) have demonstrated that nerve terminal
branches are retracted from dying muscle ®bers, an argu-DISCUSSION
ment could be made that muscle ®ber apoptosis precedes,
and in fact induces, the retraction of motor nerve terminalsThe results reported here demonstrate that the survival
of muscle ®bers is regulated directly by neuregulin and indi- from AChR-rich regions of the muscle ®ber membrane, pro-
ducing the vacated synaptic sites observed in this study.rectly by suprathreshold activity in developing muscle ®-
bers. Whereas a simple model can explain denervation and However, that both denervation and botulinum toxin-in-
duced ®ber paralysis increase the magnitude of muscle ®berparalysis-induced ®ber apoptosis (see below), the underlying
cause of naturally occurring muscle ®ber apoptosis remains apoptosis argues that loss of suprathreshold activity pre-
cedes and induces muscle ®ber apoptosis in normally devel-incompletely understood. At least in some cases naturally
occurring ®ber apoptosis appears to result from a loss of oping muscles.
This model, then, raises the question of what would in-innervation, rather than an inability of a newly formed ®ber
to acquire innervation. As reported in this study, a number duce all nerve terminal(s) to retract from a muscle ®ber?
One possibility is that the muscle ®ber failed to produceof apoptotic ®bers in normally developing muscles dis-
played well-clustered AChR plaques, and while motor ax- the retrograde factor(s) required for the maintenance of the
nerve terminals (Santo Neto et al., 1996). An alternativeons projected to these dying ®bers, they lacked terminal
arborizations, suggesting that the nerve terminal had re- hypothesis is that naturally occurring terminal Schwann
cell apoptosis or the failure of terminal Schwann cells totracted from contact with these ®bers. Additionally, termi-
nal Schwann cells were not associated with the AChR establish themselves at developing neuromuscular junc-
FIG. 5. Terminal Schwann cells as well as motor nerve terminals are absent from endplates on dying ®bers in normally developing
muscles. (A, B, C) Image of single endplate using a standard epi¯uorescent microscope. (A*, B*, C*) The same endplate imaged with a
confocal microscope. This image is presented twice because the Schwann cells were dif®cult to see with a standard epi¯uorescent
microscope, though were clear using a confocal microscope. While the AChR plaque was clearly visible using the standard epi¯uorescent
microscope, this same plaque was not bright when imaged with a confocal microscope, perhaps due to photobleaching. Schwann cells,
labeled with antibodies to S100 are shown in A, A*. Axons labeled with antibodies to neuro®lament and synaptophysin and apoptotic
myonuclei labeled with the TUNEL technique are shown in B, B*. AChRs labeled with bungarotoxin are shown in C, C*. In all panels,
the extent of the AChR plaque is marked with two horizontal white lines. (A, A*) Terminal Schwann cells fail to cover the entire extent
of the AChR plaque, leaving over half of the receptor plaque bare. (B, B*) Motor axons extend to the AChR plaque, but lack terminal
arborizations. The entire AChR plaque is devoid of innervation. An apoptotic, TUNEL-labeled myonucleus (labeled with the same
¯uorophore) is visible directly below the axon termination. (D) Color schematic of the images in A*, B*, and C* depicting the precise
overlay of the terminal Schwann cells, motor axons, and the AChR plaque. The Schwann cells are labeled in blue, the motor axons are
labeled in green, the TUNEL-labeled myonucleus is in yellow, and the AChR plaque is in red. The nerve terminations are covered by
Schwann cells, but the entire AChR plaque is lacking presynaptic structures. The bulbous axonal endings to the left and right of the main
axon may be retraction bulbs. Scale bar (upper right corner of C), 20 mm.
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tions leads to the destabilization and subsequent retraction activity in muscle ®bers and ultimately neuregulin are re-
quired the survival of some developing muscle ®bers, sug-of underlying nerve terminal arborizations (Trachtenberg
and Thompson, 1997), ultimately resulting in the death of gest the following model for how motor neurons regulate
the survival of primary muscle ®bers. Motor neuron-in-the postsynaptic muscle ®ber. This model is supported by
observations presented in this article demonstrating that duced suprathreshold activity in primary muscle ®bers [pos-
sibly requiring events associated with excitation±contrac-terminal Schwann cells are absent from synaptic sites on
dying ®bers (Fig. 5). tion coupling (Ashby et al., 1993b)] leads to an increased
expression of muscle-derived neurotrophins (most likely
NT-4). Muscle-derived neurotrophins then act on two possi-
Hypotheses on the Roles of Neuregulin and ble pathways. In the ®rst, neurotrophins act retrogradely on
Suprathreshold Activity on Muscle Fiber Survival the innervating motor neurons, ultimately leading to an
increased expression of neuregulin which is then trans-In muscles that develop in the absence of innervation,
primary muscle ®bers appear to form in normal numbers ported anterogradely to the motor nerve terminal where it
is released into the synaptic basal lamina ultimately binding(Hughes and Ontell, 1992; Ashby et al., 1993a,b). However,
the long-term survival of these ®bers requires innervation- erbB receptors on the muscle ®ber membrane. In the second,
muscle-derived neurotrophin acts in an autocrine mannerinduced suprathreshold activity (Ashby et al., 1993b). Sec-
ondary muscle ®bers, in contrast, do not appear to depend by binding Trk receptors on the muscle ®ber resulting in an
increased expression of muscle-derived neuregulin whichupon innervation for their survival (Condon et al., 1990;
Fredette and Landmesser, 1991; Hughes and Ontell, 1992; again acts in an autocrine manner, binding erbB receptor
tyrosine kinases in the muscle ®ber membrane. The netAshby et al., 1993a,b). Rather, innervation, by the depolar-
ization it induces in primary muscle ®bers, may regulate result of both of these activity-dependent pathways is an
increased expression of synaptic neuregulin and ultimatelythe number of secondary muscle ®bers that are generated
(Ross et al., 1987; Ashby et al., 1993b). Consistent with muscle ®ber survival.
In muscles paralyzed with botulinum toxin, muscle ®berthese observations, denervation of soleus muscles on post-
natal day 0 results in a signi®cant loss of slow, type 1 mus- apoptosis was increased in magnitude and was not signi®-
cantly different from the magnitude of ®ber apoptosis incle ®bers, which derive from primary muscle ®bers, but
does not appear to alter the numbers of fast muscle ®bers fully denervated muscles from age-matched littermates (Ta-
ble 1). However, in contrast to the fully denervated muscles,(Soileau et al., 1987).
Here, however, I report that in denervated, and thus inac- there were no signs of terminal Schwann cell apoptosis in
the paralyzed muscles. Terminal Schwann cells, as well astive neonatal muscles, exogenous neuregulin prevents mus-
cle ®ber apoptosis. How can the observation that neuregulin muscle ®bers, require neuregulin for their survival (Trach-
tenberg and Thompson, 1996). Thus, in the paralyzed mus-is capable of regulating muscle ®ber survival in the absence
of activity be reconciled with the observations that depolar- cles neuregulin must have been presented to the terminal
Schwann cells. Given that terminal Schwann cells are es-ization of primary muscle ®bers is required for their sur-
vival? These observations can be reconciled if innervation- sentially isolated from contact with the underlying muscle
®ber by the motor nerve terminal, this result suggests thatdependent suprathreshold activity in muscle ®bers ulti-
mately regulates the levels of synaptic neuregulins, which motor neurons continued to produce neuregulin and trans-
port it to their terminals in these paralyzed muscles. Onin turn regulate muscle ®ber survival.
Levels of the neurotrophin NT-4 in muscle ®bers have the basis of this observation it can be argued either that
muscle ®bers require higher levels of neuregulins than dobeen demonstrated to be regulated by muscle ®ber activity.
Both denervation and muscle paralysis result in a decreased terminal Schwann cells for their survival, and thus both the
muscle ®ber and the motor neuron must release neuregulinexpression of NT-4, whereas extrinsic electrical stimulation
of normally innervated or denervated muscles leads to an into the synaptic cleft to meet this requirement (with the
levels of muscle-derived neuregulin being compromised byincrease in NT-4 expression (Funakoshi et al., 1993, 1995).
Interestingly, type 1 slow muscle ®bers appear to be the paralysis), or that muscle ®bers require different isoforms
of the neuregulins (e.g., membrane bound vs soluble iso-primary source of NT-4 in muscles (Funakoshi et al., 1995).
Given that it is the slow ®bers that disappear from soleus forms) for their survival than do the terminal Schwann cells
and that it is the expression of these speci®c isoforms (e.g.,muscles denervated soon after birth (Soileau et al., 1987),
and it is slow ®bers that are generated from primary myo- the ones required for muscle ®ber survival) that is altered
by denervation and paralysis.®bers, it is reasonable to speculate that the dying ®bers
reported in this study are primary myo®bers and are thus
the primary source of NT-4. Recently, Loeb and Fischbach
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